Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2026-01-31 @ 1:45 PM
Study NCT ID:
NCT07211659
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-08
First Post:
2025-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Sponsor:
Theolytics Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
THEO-260-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None